145 related articles for article (PubMed ID: 35405593)
21. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
22. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
[TBL] [Abstract][Full Text] [Related]
24. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
Candoni A; Mestroni R; Damiani D; Tiribelli M; Michelutti A; Silvestri F; Castelli M; Viale P; Fanin R
Eur J Haematol; 2005 Sep; 75(3):227-33. PubMed ID: 16104879
[TBL] [Abstract][Full Text] [Related]
25. Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia.
Lee KH; Lim YT; Hah JO; Kim YK; Lee CH; Lee JM
Blood Res; 2017 Sep; 52(3):167-173. PubMed ID: 29043231
[TBL] [Abstract][Full Text] [Related]
26. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.
Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334
[TBL] [Abstract][Full Text] [Related]
27. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
Yi XL; Mao Q; Jiang Y; Guo XB; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1627-1630. PubMed ID: 29262887
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile].
Barraza M; Barnafi N; Ortiz G; Torres JP; Coria P; Catalán P; Palma J; Morales J
Rev Chilena Infectol; 2018 Aug; 35(4):351-357. PubMed ID: 30534920
[TBL] [Abstract][Full Text] [Related]
30. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.
Lachenmayr SJ; Berking S; Horns H; Strobach D; Ostermann H; Berger K
Mycoses; 2018 Jul; 61(7):464-471. PubMed ID: 29575106
[TBL] [Abstract][Full Text] [Related]
31. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts.
Ajmal S; Mahmood M; Abu Saleh O; Larson J; Sohail MR
Infection; 2018 Aug; 46(4):555-558. PubMed ID: 29627936
[TBL] [Abstract][Full Text] [Related]
32. Antifungal use in children with acute leukaemia: state of current evidence and directions for future research.
Yeoh DK; Haeusler GM; McMullan BJ; Butters C; Bryant PA; Clark JE; Cooper CM; Gwee A; Kotecha RS; Lai T; Slavin MA; Thursky KA; Blyth CC
J Antimicrob Chemother; 2022 May; 77(6):1508-1524. PubMed ID: 35301533
[TBL] [Abstract][Full Text] [Related]
33. Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B.
van de Peppel RJ; Schauwvlieghe A; Van Daele R; Spriet I; Van't Wout JW; Brüggemann RJ; Rijnders BJA; Hendriks BJC; de Boer MGJ
Med Mycol; 2020 Oct; 58(7):874-880. PubMed ID: 31965178
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
Fracchiolla NS; Sciumè M; Orofino N; Guidotti F; Grancini A; Cavalca F; Freyrie A; Goldaniga MC; Consonni D; Mattiello V; Pettine L; Cortelezzi A
PLoS One; 2019; 14(5):e0216715. PubMed ID: 31071175
[TBL] [Abstract][Full Text] [Related]
35. [Relevance of liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematologic malignancies].
García-Vidal C; Vázquez L; Jarque I
Rev Iberoam Micol; 2021; 38(2):61-67. PubMed ID: 33994104
[TBL] [Abstract][Full Text] [Related]
36. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
37. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
38. Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy.
Wu Y; Yan L; Wang H; Liu H; Xing L; Fu R; Shao Z
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):949-954. PubMed ID: 33219473
[TBL] [Abstract][Full Text] [Related]
39. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
[TBL] [Abstract][Full Text] [Related]
40. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
